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Abstract
Background:  Timely and accurate information is important to guide the medical treatment
process. We developed, implemented and assessed an order-entry system to support
documentation of prostate histologies involving urologists, pathologists and physicians in private
practice.
Methods: We designed electronic forms for histological prostate biopsy reports in our hospital
information system (HIS). These forms are created by urologists and sent electronically to
pathologists. Pathological findings are entered into the system and sent back to the urologists. We
assessed time from biopsy to final report (TBF) and compared pre-implementation phase (paper-
based forms) and post-implementation phase. In addition we analysed completeness of the
electronic data.
Results: We compared 87 paper-based with 86 electronic cases. Using electronic forms within the
HIS decreases time span from biopsy to final report by more than one day per patient (p < 0.0001).
Beyond the optimized workflow we observed a good acceptance because physicians were already
familiar with the HIS. The possibility to use these routine data for quality management and research
purposes is an additional important advantage of the electronic system.
Conclusion: Electronic documentation can significantly reduce the time from biopsy to final
report of prostate biopsy results and generates a reliable basis for quality management and research
purposes.
Background
Assessing advantages and disadvantages of electronic doc-
umentation is important to improve hospital information
systems. Paper-based documentation in clinical routine is
still very common because of the time needed to fill in
electronic forms [1] and reluctance to change the docu-
mentation routine [2]. On the one hand users are satisfied
with the use of routine electronic data [3], on the other
hand the subjective opinion whether electronic forms are
faster differs [2].
A recent study concerning ambulatory care in the United
States shows that although "Electronic health records have
the potential to improve the delivery of health care serv-
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ices [...] electronic systems had been adopted by only a
small minority of U.S. physicians" and only "four percent
of physicians reported having an extensive, fully func-
tional electronic records system, and 13% reported having
a basic system" [4]. In inpatient health care there are more
electronic systems but the Electronic Health Record (EHR)
"must be used by clinicians, and this remains a major
challenge" [5].
Moreover user acceptance is strongly influenced by the
perceived usefulness of a system [6]. Therefore it is impor-
tant to assess objective criteria like the turnaround time
(TAT), such as time from receipt of a specimen to the
availability of a result [7], to evaluate an electronic order-
entry system. TAT is a frequently used indicator of effi-
ciency of pathological test ordering [7-10] although the
definition of TAT may change. In contrast to laboratories,
physicians "perceive TAT as starting at the time the order
is written and ending when viewing results" [11]. The sec-
ond definition is more appropriate in our setting, where
we are addressing biopsies of prostate tumours. In addi-
tion to pathological findings, a final report is created by
the urologist. Therefore we introduced time from biopsy
to final report (TBF) as an indicator of effectiveness.
Because we analysed the whole process we measured TBF
in days and not in minutes.
The aim of this study is to compare TBF between a paper-
based and an electronic system. We present an approach
in which two paper forms previously used for documenta-
tion of prostate biopsies are transferred into the HIS to
compare these forms with HIS-based electronic forms.
This system enables shared documentation of physicians
from different departments as well as electronic orders of
histological examinations for prostate biopsies and there-
fore constitutes a computerized physician order entry sys-
tem (CPOE).
There's vast literature concerning CPOE systems whereby
most studies describe their usage for medication and pre-
scriptions [12-18] in some cases even combined with clin-
ical decision support (CDS) systems [14,19,20].
Kaushal [21], Khajouei [22] and Wolfstadt [20] reviewed
many CPOE studies which are mainly addressing medica-
tion and drug applications and focus on medication
errors. Many CPOE studies analyse risks for patient safety,
patterns of medical orders or effectiveness by TAT but
don't measure the full process time from biopsy to the
final report [14,17,21,23,24].
Our main goal was to assess a specific order-entry system
regarding documentation of prostate histologies involv-
ing urologists, pathologists and physicians in private prac-
tice. Therefore we concentrated on the following
objectives:
1. Is there a measurable time difference regarding TBF
between electronic and paper-based documentation?
2. What level of data quality is achieved in routine docu-
mentation of prostate biopsies?
3. What benefits of the electronic documentation can
increase physicians' acceptance?
Methods
We analysed the process from prostate biopsy to final
report. Clinical findings as well as the location of the spec-
imens taken are documented in the department of urol-
ogy before these data are forwarded to the department of
pathology. Pathological findings are transferred to urol-
ogy again for a final review and annotation. Previously
these forms were faxed between the department of urol-
ogy and the department of pathology and were then sent
to the referring physician. Figure 1 presents the workflow
using event-driven process chains (EPC) [25,26]. In addi-
tion, we analysed communication between the depart-
ment of urology and the department of statistics for
research purposes (Figure 2) as well as processes for qual-
ity assurance (Figure 3). Both workflows were also mod-
elled using EPC.
After analysing these processes we implemented two
forms of the prostate centre of the university clinic of
Münster using the tools of the HIS (ORBIS® from Agfa
Healthcare) [27]. Currently ORBIS® is applied to follow-
ing HIS functions: clinical documentation, administrative
documentation, order-entry and scheduling.
These forms are used for documentation of biopsies and
are similar to the previously used paper forms. The main
form is shown in figure 4. The urologist (upper yellow
part) provides clinical findings like prostate volume, PSA,
ultrasound findings and International Prostate Symptom
Score (IPSS). Pathological grading systems (Gleason score
[28], Helpap-Grading) are filled in by pathologists. After
the final assessment of the urologist in the lower part (yel-
low) of this document it is being sent to the referring phy-
sician.
We compared time from biopsy to final report (TBF)
between computer-based and paper forms. This time
depends on the delivery time of the specimen into pathol-
ogy but we want to analyse the whole process not consid-
ering the delay of the transport of the specimen. There are
about six biopsies performed per week so we looked at the
data of ten months to get representative figures.BMC Medical Informatics and Decision Making 2009, 9:5 http://www.biomedcentral.com/1472-6947/9/5
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Another indicator is time from biopsy to pathological
findings which can be used to monitor delays in this inter-
disciplinary process. Dates of the first period are manually
extracted from the paper-based documentation; dates of
computer-based forms are educed by a query using the
report generator of ORBIS® [27]. Forms without fax date
were excluded.
To assure that data sets from pre- and post implementa-
tion phase are comparable, we looked for variables which
may influence the time interval between biopsy and final
report generation. These are mainly the urologists and the
pathologists who participate in the treatment process and
the number of patients per week. Therefore we analysed
process time for both urologists separately and compared
number of patients per week, age and Gleason Score
between pre- and post-implementation phase.
To assess clinical acceptance we held contact meetings
with clinical users.
To test for significant differences in time span between
pre- and post implementation phase we used a non-para-
metric Mann-Whitney U test. Two sided p-values below
5% were considered significant. The statistical analysis
was performed with R [29].
Results
We created a first report of the paper-based forms (from
October 2007 to March 2008) and a second report of the
computer-based forms (from April 2008 to July 2008).
Prostate biopsies were mainly performed by two urolo-
gists. Table 1 shows that the number of biopsies per phy-
sician doesn't change with introduction of HIS forms. The
number of patients per week is almost the same in the pre-
and post-implementation period, too (5.7 versus 6 per
week). Further variables like age of patients (p = 0.51) and
the Gleason Score (p = 0.13) have no influence on TBF.
EPC of the diagnostic process Figure 1
EPC of the diagnostic process. An urologist performs the 
biopsy, which is sent to the pathology department. Patholog-
ical findings are combined with urologist's recommendations 
to generate the final report. Sending in the pre-implementa-
tion phase means faxing a paper form; in the post-implemen-
tation phase sending means to transfer the form 
electronically within the HIS to urology.
EPC of the research process Figure 2
EPC of the research process. The research process 
starts with definition of a research query. Data analysis is 
done in the department of statistics before urologists inter-
pret the analysed data and create a research publication.BMC Medical Informatics and Decision Making 2009, 9:5 http://www.biomedcentral.com/1472-6947/9/5
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Since introduction of computer-based forms, time span
from biopsy date until sending of the final report
decreased on average more than one day. Figure 5 shows
the frequency distribution of the pre-implementation
phase while figure 6 shows the frequency distribution of
the post-implementation phase.
The following boxplots (Figure 7) show that the median
of TBF decreases. There are some outliers which can be
traced back to delays caused by holidays in both data sets.
The median TBF in the pre-implementation-phase is 7
days versus 6 days in the post-implementation-phase.
According to Mann-Whitney-U-test this difference is
highly significant with p < 0.0001. Table 2 shows that
these time differences are consistent for urologist A and B.
From a quality management perspective, the biopsy tissue
must be placed in some dilution for one night, so the opti-
mal result is a time span of one day. The average time span
was one week. Therefore an average decrease by one day is
a relevant result. In contrast to the paper-based system, the
electronic system provides a method to regularly measure
TBF.
Secondary use of prostate biopsy data
Furthermore, the electronic system enables to monitor the
documentation process regarding completeness, delays
and observed coherences. Completeness of documenta-
tion is important for data analysis in clinical research. Fig-
ure 8 shows the relation of the prostate volume to the
result of the biopsy. This figure is based on routine data.
All participating physicians rated decreased time and the
possibility to create reports on routine data as relevant
advantages of the system. Referring physicians gave posi-
tive feedback about fast and well readable final reports in
the post-implementation phase.
Discussion
Our analysis shows that the prostate biopsy workflow can
be accelerated significantly by replacing paper-based doc-
umentation with electronic HIS forms. The acceptance of
this solution was very good because the paper-based
forms were nearly identically transformed to HIS and the
physicians were already familiar with the HIS.
Advantages like well-readable documents and input sup-
port by catalogues and text modules confirm the opinion
of the users that such a system is superior to paper-based
documentation. Our study is focused on a concrete order-
entry process for prostate tumour, but our approach could
be extended to optimize the documentation workflow of
other tumour entities since many processes are not inte-
grated in the current IT environment of the university hos-
pital.
Furthermore the data are now stored in the HIS. This
allows the design of reports to monitor completeness of
forms and individual variables like Gleason score. Within
the evaluation we observed that the completeness of the
routine data was very high partly due to initialisation of
some data fields and due to automatic calculations (e.g.
exact psa quotient). Especially the well known problem of
missing values is eliminated through controlled value
lists. Coherences like the relation between prostate vol-
ume and malignity are only meaningful if the data are
complete. So we observed similar results to Bürkle et al.
[30] that increasing computerized documentation can
result in better data quality.
Positive effects of computerized documentation could
also be found in many studies concerning CPOE. There
are "many different commercial and home-made systems
available and each of them needs to be carefully evalu-
ated" [14]. But present quantitative studies are few in
number and analyse mainly the number of pathological
orders [23] or prescriptions [17] as well as effects on
patient safety [14,17,21,24]. In most studies effectiveness
of a CPOE system is analysed by measuring TAT according
EPC of the quality assurance process Figure 3
EPC of the quality assurance process. For quality assur-
ance QA data is exported and transferred to the department 
of quality assurance. After answering enquiries by urologists 
the final QA report is created.BMC Medical Informatics and Decision Making 2009, 9:5 http://www.biomedcentral.com/1472-6947/9/5
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Prostate biopsy form Figure 4
Prostate biopsy form. In the upper part fax date ("Fax gesendet am"), the time of biopsy ("Biopsie Datum"), PSA and pros-
tate volume ("Prostatavolumen") are recorded. Up to 12 specimens can be documented with length of the biopsy core ("Länge 
gesamt"), percentage tumour in biopsy core, and Gleason score ("Gleason Summe"). The yellow part is provided by urologists, 
the rest is documented by pathologists.BMC Medical Informatics and Decision Making 2009, 9:5 http://www.biomedcentral.com/1472-6947/9/5
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to the definition of laboratories as the time from receipt of
the specimen until availability of test result [11].
Our main goal was a quantitative analysis of our CPOE
system within the HIS by measuring time from biopsy to
final report (TBF) to assess duration of the whole medical
process. Hurlen et al. introduced a similar indicator by
defining report turnaround time (RTAT) to measure not
only the technology but take care that the direct "involve-
ment of key actors and [...] are important [...] for sustain-
ing positive results" [31].
In particular, the available literature regarding quantita-
tive effects of CPOE on speed of medical processes is lim-
ited. Furthermore most studies analyse separate CPOE
systems since many systems aren't integrated in HIS [12]
although benefits often realised by institutions using
home grown systems [32].
Table 1: Basic data of the analysed forms
Oct-Mar Apr-Jul
analysed forms 87 86
urologist A 47 (54%)1,2 47 (54.7%)1
urologist B 35 (40.2%)1,2 39 (45.3%)1
Patients/week 5.7 6
Gleason Score 7 (7 to 9)3 7 (6 to 7)3
Age 67 (59 to 71)3 65 (58 to 70)3
1biopsies per urologist (percentage) 2missing percent other physicians 
3median (IQR)
Number of analysed forms and comparison of the periods concerning 
physician, age and Gleason Score.
Pre-implementation phase: Frequency distribution of time  from biopsy to final report Figure 5
Pre-implementation phase: Frequency distribution of 
time from biopsy to final report. Without the forms in 
ORBIS® it takes about 1 week after the biopsy to send a final 
report.
Post-implementation phase: Frequency distribution of TBF Figure 6
Post-implementation phase: Frequency distribution 
of TBF. With the new forms in ORBIS® it takes about 5–6 
days to send a final report. In addition, the proportion of 
cases with 1–4 days is increased.
Boxplots of time from biopsy to final report Figure 7
Boxplots of time from biopsy to final report. TBF is 
lower in the computer-based period.BMC Medical Informatics and Decision Making 2009, 9:5 http://www.biomedcentral.com/1472-6947/9/5
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Routine HIS data can be used for quality management, for
instance to benchmark time from biopsy to clinical
report. It can also be applied for clinical research, for
example to analyse the proportion of different subtypes of
prostate cancer. For this reason, our study is a "single-
source"-approach [33], i.e. to use HIS data for clinical rou-
tine as well as research. Especially at a university hospital
this is a relevant factor for user acceptance.
There was no introduction phase for the electronic system,
because the second phase started directly after the first
one. In other studies there were two post-implementa-
tions periods [6,7] to eliminate distracting influence of
the introduction phase. Because our users were already
familiar with the HIS, we expect this effect to be small, but
we plan to repeat our analysis in a few months.
In the future we intend to expand and analyse our
approach for other departments with tumour documenta-
tion.
Conclusion
Electronic documentation within the HIS can significantly
reduce the time from biopsy to final report. From our
experience it is important to foster the approach to inte-
grate paper forms into the HIS to gain advantages like
time saving, optimized workflow and structured docu-
mentation within the HIS. The single source idea is highly
accepted by physicians and provides new possibilities like
quality monitoring through reports.
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